Mind Medicine (MindMed) Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Mind Medicine (MindMed) Inc. (MNMD) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-108.68-95.73-56.80-93.04-33.94
Depreciation & Amortization0.033.163.180.020.00
Stock Based Compensation17.6715.1813.7142.727.41
Change in Working Capital-3.346.28-3.781.882.06
Change in Accounts Payable-2.132.03-2.061.280.54
Change in Other Working Capital-1.220.470.041.761.52
Other Operating Activities13.970.475.9142.720.87
Net Cash from Operating Activities-79.13-64.37-50.14-45.82-23.60
Investing Activities
Acquisitions0.000.000.00-0.300.00
Net Cash from Investing Activities0.000.000.00-0.300.00
Financing Activities
Debt Repayment-0.13-0.840.000.000.00
Common Stock Issued259.977.5342.3098.8297.10
Common Stock Repurchased-0.050.00-0.410.000.00
Other Financing Activities-16.720.11-0.410.00-0.40
Net Cash from Financing Activities253.2021.8559.0598.8296.70
Summary
Effect of Forex Changes on Cash-0.030.08-0.310.740.00
Net Change in Cash174.04-42.528.9153.4573.39
Cash at Beginning of Period99.70142.14133.5480.090.00
Cash at End of Period273.7499.70142.14133.540.00
Free Cash Flow-79.13-64.37-50.14-45.820.00
Supplemental Disclosures
Interest Paid2.220.530.000.000.00